Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Westerberg

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Scandinavian Journal of Urology|March 25, 2026
Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy resultsEugenio Ventimiglia, Rolf Gedeborg, Marcus Westerberg, et al.
European Urology Open Science|July 23, 2025
Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Prostate Cancer-specific Death in Sweden: A Population-based Cohort StudyRenata Zelic, Marcus Westerberg, Pär Stattin, et al.
Journal of Clinical Epidemiology|December 20, 2022
Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidenceMarcus Westerberg, Kerri Beckmann, Rolf Gedeborg, et al.
Scientific Reports|December 26, 2025
Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancerMarcus Westerberg, Hans Garmo, Jesper Bonnedahl, et al.
Plos One|November 23, 2022
Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancyAndri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate CancerPietro Scilipoti, Ola Bratt, Hans Garmo, et al.
Plos One|January 30, 2020
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register studyFrederik B Thomsen, Marcus Westerberg, Hans Garmo, et al.
Journal of Internal Medicine|June 7, 2024
Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trialMarcus Westerberg, Julia Eriksson, Chris Metcalfe, et al.
European Urology Open Science|June 19, 2026
Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based StudyEugenio Ventimiglia, Marcus Westerberg, Andri Wilberg Orasson, et al.
European Urology Open Science|October 3, 2022
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based DataEugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Scandinavian Journal of Urology|March 25, 2026
Nationwide population-based longitudinal data on magnetic resonance imaging of the prostate and subsequent prostate biopsy resultsEugenio Ventimiglia, Rolf Gedeborg, Marcus Westerberg, et al.
European Urology Open Science|July 23, 2025
Adaption of the Memorial Sloan Kettering Cancer Center Nomograms for the Prediction of Prostate Cancer-specific Death in Sweden: A Population-based Cohort StudyRenata Zelic, Marcus Westerberg, Pär Stattin, et al.
Journal of Clinical Epidemiology|December 20, 2022
Choice of imputation method for missing metastatic status affected estimates of metastatic prostate cancer incidenceMarcus Westerberg, Kerri Beckmann, Rolf Gedeborg, et al.
Scientific Reports|December 26, 2025
Optimised comorbidity indices can reflect patient performance status in register based studies of prostate cancerMarcus Westerberg, Hans Garmo, Jesper Bonnedahl, et al.
Plos One|November 23, 2022
Diagnostic activity impacts lifetime risk of prostate cancer diagnosis more strongly than life expectancyAndri Wilberg Orrason, Marcus Westerberg, Peter Albertsen, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 10, 2025
Long-Term Outcomes After Guideline-Recommended Treatment of Men With Prostate CancerPietro Scilipoti, Ola Bratt, Hans Garmo, et al.
Plos One|January 30, 2020
Prediction of metastatic prostate cancer by prostate-specific antigen in combination with T stage and Gleason Grade: Nationwide, population-based register studyFrederik B Thomsen, Marcus Westerberg, Hans Garmo, et al.
Journal of Internal Medicine|June 7, 2024
Colonoscopy findings after increasing two-stool faecal immunochemical test (FIT) cut-off: Cross-sectional analysis of the SCREESCO randomized trialMarcus Westerberg, Julia Eriksson, Chris Metcalfe, et al.
European Urology Open Science|June 19, 2026
Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based StudyEugenio Ventimiglia, Marcus Westerberg, Andri Wilberg Orasson, et al.
European Urology Open Science|October 3, 2022
Modeling Disease Trajectories for Castration-resistant Prostate Cancer Using Nationwide Population-based DataEugenio Ventimiglia, Anna Bill-Axelson, Jan Adolfsson, et al.
Pageof 6